Cargando…
Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Urologia
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881804/ https://www.ncbi.nlm.nih.gov/pubmed/36512463 http://dx.doi.org/10.1590/S1677-5538.IBJU.2023.01.04 |
| _version_ | 1784879188732280832 |
|---|---|
| author | Barros, Rodrigo de Castro |
| author_facet | Barros, Rodrigo de Castro |
| author_sort | Barros, Rodrigo de Castro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9881804 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedade Brasileira de Urologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98818042023-01-29 Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy Barros, Rodrigo de Castro Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2023-01-26 /pmc/articles/PMC9881804/ /pubmed/36512463 http://dx.doi.org/10.1590/S1677-5538.IBJU.2023.01.04 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Update in Urology Barros, Rodrigo de Castro Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title | Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title_full | Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title_fullStr | Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title_full_unstemmed | Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title_short | Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| title_sort | editorial comment: secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy |
| topic | Update in Urology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881804/ https://www.ncbi.nlm.nih.gov/pubmed/36512463 http://dx.doi.org/10.1590/S1677-5538.IBJU.2023.01.04 |
| work_keys_str_mv | AT barrosrodrigodecastro editorialcommentsecondarypolycythemiainmenreceivingtestosteronetherapyincreasesriskofmajoradversecardiovasculareventsandvenousthromboembolisminthefirstyearoftherapy |